Biosortia Pharmaceuticals

mining and harvesting the world’s most sought after microbial chemistry for a unique library of cellular signaling compounds. pre-clinical portfolio of microbiome-derived immuno-modulating peptides with exclusive technologies and the scientific expertise for discovering and expanding and advancing a valuable io/i pipeline extract value from natural and chemically modified compounds primary strategy: • deep dive into metabolome • concentration of minor metabolites • fractionanation to simplified pools for testing • high rate of structured novelty • priority driven by biological activity (ip created) • potential to go directly to the organism derivative strategy: • modify major metabolites • novel chemistry creates ip positions • abundant by-product compounds • one-step chemistry transforms adme properties • available for broad screening as pure compounds • synthetic gmp (ip creates) we seek a research relationship in a specific therapeutic area for exclusive access to the cell to cell s